Sign in or create a free account to view this dataset's chart and data table.
Key Takeaway
- Musculoskeletal system medicines recorded a CAGR of 5% between FY 2019–20 and FY 2024–25. The category includes anti-inflammatory agents, counter-irritants, rubefacients and poultices. The positive CAGR indicates steady sales expansion over the period.
About This Dataset
Annual sales data for animal health musculoskeletal products, including anti-inflammatory agents, counter-irritants, rubefacients and poultices. These products are used to manage inflammation, discomfort and related musculoskeletal conditions in animals. The dataset presents aggregated sales by financial year from 1 July to 30 June.
Methodology
Sign in or create a free account to view this dataset's methodology and sources.
Available formats: Excel, CSV, PNG, PDF.
Transform Data Into Better Business Decisions
Join organizations that rely on statSCALAR for trusted market intelligence, industry statistics, commodity insights and enterprise research.